Saiz Martinez 2016.

Study characteristics
Methods	Study design: non‐randomised intervention study Country: Spain Data collection period: not stated Registry ID: not reported
Participants	Number of participants: N = 81 Sample characteristics (at baseline): Age (mean): 43.4 years (SD 8.8); Sex (% male): 72.8% Population category: psychiatric population; Specific population: People with schizophrenia allocated to continue smoking or take varenicline or use NCT patches Nicotine dependence: not measured; Baseline cigarettes per day: 28 (SD 12.3); Motivation to quit: not selected by motivation to quit
Interventions	Behavioural support for smoking cessation: no behavioural support Pharmacological support for smoking cessation: Varenicline or NCT patches, no further details. Psychotherapeutic or psychoactive support for mental health or mood: did not receive mood management
Outcomes	Definition of cessation used: not reported Cessation definition used for outcome(s) in this analysis: unclear definition Measure of biovalidation: not reported Definition of people who continued to smoke used: not reported Time point(s) at which follow‐up was conducted: 3 and 6 months Outcome category: Depression, Mixed Anxiety + Depression, Positive Affect Outcome measure(s): Hamilton Depression Rating Scale (HDRS); Positive and Negative Syndrome Scale (PANSS)
Funding source	None specified
Author conflicts of interest	Authors have not supplied their declaration of competing interest
Notes	Outcome data source: Published data